Professional Experience
Dr. Cortés has held leadership positions at major oncology centers in Spain. He combines clinical expertise with management and research experience, ensuring high-quality patient care.
- Current Position: Breast Cancer Program Director, Hospital Ruber Internacional, Madrid
- Co-Founder: IOB Institute of Oncology, Madrid
- Previous Roles: Head of Breast Cancer and Melanoma Unit, Vall d’Hebrón Instituto de Oncología (VHIO), Barcelona; Head of Breast Cancer and Gynecological Tumors Unit, Hospital Ramón y Cajal, Madrid
- Leadership: Coordinated oncology residency programs, supervised clinical teams, and mentored junior doctors
Academic Contributions
Dr. Cortés actively contributes to academic research, international conferences, and medical education. His work advances breast cancer knowledge and improves patient outcomes worldwide.
- Over 330–400 international publications focused on breast cancer research
- Delivered more than 600 presentations at national and international oncology conferences
- Peer reviewer for high-impact journals including New England Journal of Medicine, The Lancet, Annals of Oncology, and Journal of Clinical Oncology
- Committee member and chair/co-chair roles at ESMO and AACR conferences
Areas of Expertise
Dr. Cortés provides specialized care for complex cancer cases, focusing on advanced diagnostics and innovative therapies.
- Breast Cancer: HER2-positive, triple-negative, and other aggressive subtypes
- Gynecological Tumors: Ovarian, uterine, and cervical cancer
- Advanced Treatments: Targeted therapy, immunotherapy, chemotherapy, and combination regimens
- Clinical Trials: Participation in innovative studies providing patients access to new therapies
Publications and Research
Dr. Cortés has made significant contributions to oncology research, translating scientific discoveries into real-world patient benefits.
- Published 330–400+ international articles in leading oncology journals
- Key role in clinical trials for approval of drugs such as pertuzumab, bevacizumab, eribulin, pembrolizumab, and trastuzumab-deruxtecan
- Research focus on immunotherapy for triple-negative breast cancer to improve response rates
- Active in translating research into practical treatment strategies for patients
Patient Care Philosophy
Dr. Cortés emphasizes compassionate and personalized care, ensuring patients understand their treatment options and feel supported throughout therapy.
- Focuses on empathy, clear communication, and patient education
- Offers access to advanced therapies and clinical trials for aggressive cancers
- Supports international patients with coordinated care and online pre-consultations
- Prioritizes cultural sensitivity and patient satisfaction
Professional Affiliations
Dr. Cortés holds active memberships and leadership roles in national and international oncology organizations, reinforcing his professional credibility.
- Member of Sociedad Española de Oncología Médica (SEOM), European Society for Medical Oncology (ESMO), and American Society of Clinical Oncology (ASCO)
- Scientific Committee member at ESMO; Chair/Co-chair roles at AACR conferences
- Co-founder of Medica Scientia Innovation Research (MedSIR)
- President of Fundación Contigo contra el cáncer de la mujer and patron of Fundación Oncoayuda
FAQs
- Is Dr. Javier Cortés Castán board-certified?
- Yes. He is a certified medical oncologist, having completed his specialization at Clínica Universitaria de Navarra.
- What types of cancers does he treat?
- He specializes in breast cancer, including HER2-positive and triple-negative subtypes, as well as gynecological tumors such as ovarian, uterine, and cervical cancer.
- Does he treat international patients?
- Yes. Dr. Cortés accepts international patients and provides coordinated care, including online pre-consultations.
- Does he participate in clinical trials and advanced treatments?
- Yes. He leads and participates in multiple international clinical trials for innovative cancer therapies.
- What languages does he speak?
- Primarily Spanish. International patient coordination services are available for non-Spanish speakers.
- How long is the typical hospital stay for treatments under his care?
- The length of stay depends on the type of therapy and patient condition. Specific durations should be confirmed with the hospital.
- Is Dr. Cortés suitable for complex or advanced breast cancer cases?
- Yes. He has extensive experience treating advanced or complex breast cancer, including aggressive subtypes, with access to cutting-edge therapies and clinical trials.
